TCE-RRMM

Clinical trials for TCE-RRMM explained in plain language.

Never miss a new study

Get alerted when new TCE-RRMM trials appear

Sign up with your email to follow new studies for TCE-RRMM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New study to see how elranatamab fights tough myeloma in china

Disease control Not yet recruiting

This study will observe about 159 adults in China with a hard-to-treat type of multiple myeloma that has come back or not responded to other treatments. Researchers will track how well the drug elranatamab works in everyday medical practice, looking at tumor shrinkage, survival, …

Matched conditions: TCE-RRMM

Sponsor: Peking University People's Hospital • Aim: Disease control

Last updated May 17, 2026 03:25 UTC

TCE-RRMM

Get alerted when new TCE-RRMM trials appear

New study to see how elranatamab fights tough myeloma in china